Outcomes of rectal cancer patients who refuse surgery after incomplete clinical response to neoadjuvant therapy.
Kevin P LabadieKristofor A OlsonSteven H SunPhilip H G ItuarteMark H HannaYasmin ZerhouniLily L LaiStephen M SentovichAndreas M KaiserKurt A MelstromPublished in: Journal of surgical oncology (2024)
A significant portion of patients convert to cCR and have prolonged OS. Lengthening the time to declare cCR may be considered in select patients, such as those with a near cCR at initial endoscopic staging.
Keyphrases
- end stage renal disease
- rectal cancer
- ejection fraction
- chronic kidney disease
- newly diagnosed
- dendritic cells
- lymph node
- peritoneal dialysis
- regulatory t cells
- stem cells
- squamous cell carcinoma
- minimally invasive
- type diabetes
- immune response
- patient reported outcomes
- skeletal muscle
- coronary artery bypass
- atrial fibrillation
- weight loss
- replacement therapy
- surgical site infection